TrialPloS one2019

A novel point-of-care oral anti-HCV assay: Is it reliable for screening hepatitis C virus infection in the era of direct-acting antivirals?

Rui-Feng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.